Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
Curis priced a $8.5M private placement of 16,666,680 shares (or pre-funded warrants) with accompanying warrants at an effective $0.51 per share, in an at-the-market offering under Nasdaq rules. The deal includes deep dilution mechanics: existing warrants previously exercisable at $15.00 and $1.75 are repriced down to $0.60, and new penny-warranted shares carry five-and-a-half-year terms.
Key figures
- Deal Value Usd
- 8500000
- Offering Price
- 0.51
- Shares Offered
- 16666680
- Runway
- funds operations through initial CLL data in 5-10 patients in December 2026
- Repriced warrants
- January 2026 warrants (1,126,676 shares, from $15.00) and August 2026 warrants (3,733,334 shares, from $1.75) reduced to $0.60
- Warrant exercise price
- 0.6
- Prefunded warrant exercise price
- 0.01
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.